Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein- positive clustered cells from the peripheral blood of breast cancer patients

International Journal of Cancer

Volumn 76, Issue 6, 1998, Pages 824-828

  Brandt, Burkhard ^a   Roetger, Antje ^a   Heidl, Stefan ^a   Jackisch, Christian ^a   Lelle, Ralf J ^a   Assmann, Gerd ^a   Zänker, Kurt S ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST CANCER; CELL ISOLATION; DIAGNOSTIC VALUE; EPITHELIUM CELL; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CELL SEPARATION; EPITHELIAL CELLS; FEMALE; HUMANS; KERATINS; MALE; NEOPLASM METASTASIS; RABBITS; RECEPTOR, ERBB-2;

EID: 0032503489     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980610)76:6<824::AID-IJC10>3.0.CO;2-2     Document Type: Article

References (29)

1. ALLRED, D., CLARK, G.M., TANDON, A. and MCGUIRE, W.L., Her-2/neu expression identifies a group of node-negative breast cancer patients at high risk for recurrence. Proc. Amer. Soc. clin. Oncol., 9, 435 (1990).
2. ANDERSEN, T.I., PAUS, E. and NESLAND, J.M., Detection of c-erbB-2 related protein in sera from breast cancer patients. Acta Oncol., 34, 499-504 (1995).
3. BARGMANN, C.I., HUNG, M.C. and WEINBERG, R.A., The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (Lond.), 319, 226-230 (1986).
4. BRANDT, B., JUNKER, R., GRIWATZ, C., HEIDL, S., BRINKMANN, O., SEMJONOW, A., ASSMANN. G. and ZÄNKER, K.S., Isolation of prostate-derived single cells and clustered cells from human peripheral blood. Cancer Res., 56, 4556-4561 (1996).
5. BRANDT, B., VOGT, U., C.M. SCHLOTTER, JACKISCH, C., WERKMEISTER, R., THOMAS, M., VON EIFF, M., BOSSE, U., ASSMANN, G. and ZÄNKER, K.S., Prognostic relevance of aberrations of the erbB oncogenes in breast, ovarian, oral and lung cancer: double-differential PCR for clinical diagnosis. Gene. 159, 35-42 (1995).
6. BRUGGER, W., BROSS, K.J., GLATT, M., WEBER, F., MERTELSMANN, R. and KANZ, L., Mobilization of tumor cells and hematopoetic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83, 636-640 (1994).
7. DEBUS, E., MOLL, R., FRANKE, W.W., WEBER, K. and OSBORN, M., Immunohistochemical distinction of human carcinoma by cytokeratin typing with monoclonal antibodies. Amer. J. Pathol., 114, 121-130 (1984).
8. FIDLER, I.J., Critical factors in the biology of human cancer metastasis: 28th G.H.A. Clowes Memorial Award Lecture. Cancer Res., 50, 6130-6138 (1990).
9. FISHER, B., Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer, 4, 574-587 (1977).
10. FRIEDL, P., NOBLE, P.B., WALTON, P.A., LAIRD, D.W., CHAUWIN, P.J., TABAH, R.J., BLACK M. and ZÄNKER, K.S., Migration of coordinated clustered cells in mesenchymal and epithelial cancer explants in vitro. Cancer Res., 55, 4557-4560 (1995).
11. GRIWATZ, C., BRANDT, B., ASSMANN, G. and ZÄNKER, K.S., An immunological enrichment method for epithelial cells from peripheral blood. J. Immunol. Meth., 183, 251-265 (1995).
12. GULLICK, W.J., BERGER, M.S. and BENNETT, P.L.P., Expression of the c-erbB-2 protein in normal and transformed cells. Int. J. Cancer, 40, 246-251 (1987).
13. GUSTERSON, B.A. and 20 OTHERS, Prognostic importance of c-erb B-2 expression in breast cancer. J. Clin. Oncol., 10, 1049-1056 (1992).
14. MUSS, H.B., THOR, A.D. and BERRY, D.A., c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N. Engl. J. Med., 330, 1260-1266 (1994).
15. NIEHANS, G.A., SINGLETON, P.S., DYKOSKI, D. and KIANG, D., Stability of Her-2/neu expression over time and at multiple metastatic sites. J. nat. Cancer Int., 85, 1235-1240 (1993).
16. OSBORN, M. and WEBER, K., Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab. Invest., 48, 372-394 (1983).
17. PAIK, S., HAZAN, R. and FISHER, E.R., Pathologic findings from the National Surgical Adjuvant Breast Cancer and Bowel Project: prognostic significance of erb B-2 protein overexpression in primary breast cancer. J. Clin. Oncol., 8, 103-112 (1990).
18. PANTEL, K., SCHLIMOK, G., BRAUN, S., KUTTER, D., LINDEMANN, F., SCHALLER, G., FUNKE, I., IZBICKI, J.R. and RIETHMÜLLER, G., Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. nat. Cancer Inst., 85, 1419-1423 (1993).
19. RAVDIN, P.M. and CHAMNESS, G.C., The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers. Gene, 159, 19-27 (1995).
20. RIESENBERGER, R., OBERNEDER, R., KRIEGMAIR, M., and PANTEL, K., Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells. Histochemistry, 99, 61-66 (1993).
21. SILEN, A., WIKLUND, B., ANDERSSON, E.L. and NILSSON, S., A novel IRMA and ELISA for quantifying cytokeratin 8 and 18 fragments in the sera of healthy individuals and cancer patients. Scand, J. clin. Lab. Invest., 55, 153-161 (1995).
22. SIMPSON, S.J., VACHULA, M., KENNEDY, M.J., KAIZER, H., COON, J.S., GHALIE, R., WILLIAMS, S. and VAN EPPS, D., Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp. Hematol., 23, 1062-1068 (1995).
23. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
24. VAN DE VIJVER, M.J., PETERSE, J.L., MOOI, W.J., WISMAN, P., LOBMANS, J., DALESIO, O. and NUSSE, R., Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N. Engl. J. Med., 319, 1239-1245 (1988).
25. YAMAMOTO, T., IKAWA, S. and AKIYAMA, T., Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor. Nature (Lond.), 319, 230-234 (1986).
26. YOKOTA, J., TOYOSHIMA, K., SUGIMURA, T., YAMAMOTO, T., TERADA, M., BATTIFORA, H. and CLINE, M.J., Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet, i, 765-766 (1986).
27. YU, D., HAMADA, J.-L., ZHANG, H., NICOLSON, G.L. and HUNG, M.C., Mechanisms of neu oncogene induced metastasis and abrogation of metastatic properties by the adenovirus 5 E1A gene products. Oncogene, 7, 2263-2270 (1992).
28. YU, D. and HUNG, M.C., Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene, 6, 1991-1196 (1991).
29. YU, D., WAND, S.S., DULSKI, K.M., TSAI, C.M., NICOLSON, G.L. and HUNG, M.C., c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54, 3260-3266, 1994.